Nathaniel David
Nathaniel David | |
|---|---|
| Born | San Francisco, California, U.S. |
| Nationality | American |
| Alma mater | Harvard University, University of California, Berkeley |
| Known for | Kythera Biopharmaceuticals, Kybella, Jupiter Bioventures |
| Awards | MIT Technology Review Young Innovators Under 35 |
| Scientific career | |
| Fields | Biotechnology |
| Institutions | Kythera Biopharmaceuticals, Unity Biotechnology, Jupiter Bioventures |
Nathaniel David is an American scientist and biotechnology entrepreneur who has co-founded several life sciences companies that together have raised more than $1.5 billion in financing and contributed to the development of multiple FDA-approved medicines, including alogliptin, trelagliptin, Zemiglo (Zemdi), Zemdri, and Kybella.